Article Information
PubMed
Published By
History
- Received October 5, 2009
- Revision received January 11, 2010
- Accepted January 13, 2010
- First published March 4, 2010.
- Version of record published March 4, 2010.
Copyright & Usage
Copyright © 2010 the authors 0270-6474/10/303409-10$15.00/0
Author Information
- Elpida Tsika 1 , 4 ,
- Maria Moysidou 1 , 4 ,
- Jing Guo 1 ,
- Mimi Cushman 1 ,
- Patrick Gannon 3 ,
- Raphael Sandaltzopoulos 4 ,
- Benoit I. Giasson 3 ,
- Dimitri Krainc 5 ,
- Harry Ischiropoulos 1 , 2 , 3 , and
- Joseph R. Mazzulli 1 , 5
- 1The Children's Hospital of Philadelphia Research Institute and
- 2Departments of Pediatrics and
- 3Pharmacology, The Children's Hospital of Philadelphia and The University of Pennsylvania, Philadelphia Pennsylvania 19104,
- 4Department of Molecular Biology and Genetics, Democritus University of Thrace, Alexandroupolis, Greece, and
- 5Department of Neurology, Massachusetts General Hospital, Harvard Medical School, MassGeneral Institute for Neurodegenerative Disease, Charlestown, Massachusetts 02129
- Correspondence should be addressed to either of the following: Dr. Joseph R. Mazzulli, MassGeneral Institute for Neurodegenerative Disease, CNY Building, 114 16th Street, Neurology/114-2001, Charlestown, MA 02129-4404, jmazzulli{at}partners.org; or Dr. Harry Ischiropoulos, Children's Hospital of Philadelphia, 417 Abramson Research Center, 3517 Civic Center Boulevard, Philadelphia, PA 19104-4318, E-mail: ischirop{at}mail.med.upenn.edu
Author contributions
Disclosures
- Received October 5, 2009.
- Revision received January 11, 2010.
- Accepted January 13, 2010.
-
This work was supported by the National Institutes of Health Grants AG09215 (B.I.G), NS053488 (B.I.G.), and R01NS051303 (D.K.), United States Public Health Service Grant AG13966 (H.I.), National Institute of Environmental Health Sciences Center of Excellence in Environmental Toxicology Grant ES013508 (H.I), and National Institute of Neurological Disorders and Stroke Award F32NS066730 (J.R.M.). H.I. is the Gisela and Dennis Alter Research Professor of Pediatrics.
- Correspondence should be addressed to either of the following: Dr. Joseph R. Mazzulli, MassGeneral Institute for Neurodegenerative Disease, CNY Building, 114 16th Street, Neurology/114-2001, Charlestown, MA 02129-4404, jmazzulli{at}partners.org; or Dr. Harry Ischiropoulos, Children's Hospital of Philadelphia, 417 Abramson Research Center, 3517 Civic Center Boulevard, Philadelphia, PA 19104-4318, E-mail: ischirop{at}mail.med.upenn.edu
